11/09/2026
🚨 Vet professionals – GFI needs your input! 🚨
This proposed guidance from the FDA could potentially reduce access to cGMP-produced office-stock medications and create additional costs, waste and, administrative burdens for veterinary practices and animal owners.
This is your opportunity to tell FDA what that could mean for your patients and your day-to-day practice. Comments before November 27, 2026 to prevent further action!
Our free tool helps you turn your own experience into a comment in about five minutes. Learn more and build your comment: https://epicurpharma.com/gfi_256b/